South Korea Wearables in Pharma & Biotech Market (2026-2031)
The South Korea Wearables in Pharma & Biotech Market was valued at $50.6 Million in 2026 and projected to reach to $124.7 Million by 2031, representing a compound annual growth rate of 19.8%. South Korea's wearables in pharma and biotech market is poised for substantial growth through 2031, supported by the country's advanced technological infrastructure and healthcare system maturity.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
South Korea Wearables in Pharma & Biotech Market Trends and Insights
- This expansion reflects South Korea's advanced healthcare infrastructure, strong digital health adoption, and significant investment in medical device innovation.
- South Korea's position as a global technology leader has accelerated the integration of wearable sensors and monitoring devices into pharmaceutical and biotech applications, driving clinical trial efficiency and patient engagement. The South Korea market benefits from favorable regulatory frameworks and a highly digitalized population receptive to health monitoring technologies.
- South Korea's pharmaceutical companies and biotech firms are increasingly leveraging wearables for real-world evidence collection, remote patient monitoring, and personalized medicine initiatives.
- Between 2026 and 2031, South Korea is expected to maintain its competitive edge through continued R&D investment and strategic partnerships between tech and life sciences sectors, positioning the country as a key hub for wearable pharma innovation in the Asia Pacific region..
Key Market Statistics
- CAGR (2026-2031) 19.8% CAGR
- Market Size, 2026 ~USD 50.6 Million
- Forecast, 2031 ~USD 124.7 Million
- Country South Korea
South Korea Wearables in Pharma & Biotech Market Overview
Rapid Market Expansion :
South Korea's wearables in pharma and biotech market is projected to grow from $50.6 million in 2026 to $124.7 million by 2031, representing a 19.8% CAGR, driven by technological advancement and healthcare digitalization.
Tech-Driven Innovation Hub :
South Korea's position as a global technology leader has accelerated the adoption of wearable medical devices, with major electronics manufacturers integrating biotech capabilities into consumer and clinical products.
Advanced Healthcare Infrastructure :
South Korea's sophisticated healthcare system and high digital health adoption rates create an ideal environment for wearable pharma and biotech solutions, supporting seamless integration into clinical workflows.
Government & Industry Investment :
Significant government funding and private sector investment in medical device innovation and digital health initiatives are propelling South Korea's wearables market growth and competitive positioning.
South Korea Wearables in Pharma & Biotech Market Dynamics
- The market benefits from strong consumer adoption of health monitoring devices and increasing integration of wearables into clinical diagnostics and patient management protocols.
- South Korea's major electronics conglomerates are actively developing pharmaceutical-grade wearables, creating synergies between consumer tech and biotech sectors. The forecast period will see accelerated innovation in remote patient monitoring, continuous glucose monitoring, and cardiac wearables tailored to South Korean healthcare standards.
- Regulatory support from the Korean FDA and collaboration between tech companies and pharmaceutical firms will drive market penetration.
- Additionally, aging demographics and rising chronic disease prevalence will increase demand for wearable-based preventive healthcare solutions, positioning South Korea as a regional leader in pharma-biotech wearables..
Related Ecosystem
Healthcare It
- Computed Tomography (CT)
- Machine Learning
- Magnetic Resonance Imaging (MRI)
- Natural Language Processing (NLP)
- Predictive Analytics
- CERNER CORPORATION
- PHILIPS HEALTHCARE
- Oracle Corporation
- GE HealthCare Technologies Inc.
- Siemens healthineers
Key Takeaways
- South Korea's wearables in pharma & biotech market is valued at $50.6 million in 2026 and will reach $124.7 million by 2031, representing a 19.8% CAGR.
- South Korea's advanced technology ecosystem and digital health infrastructure position it as a leader in wearable pharma innovation within Asia Pacific.
- South Korea's pharmaceutical and biotech sectors are increasingly adopting wearables for clinical trials, real-world evidence, and remote patient monitoring.
- South Korea's favorable regulatory environment and tech-savvy population support accelerated market expansion through 2031.
Wearables in Pharma & Biotech Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2026 |
| Fastest Growing Segment | MENTAL HEALTH & BEHAVIORAL HEALTH (Therapeutic Area) |
| Forecast Period | 2026–2031 |
| Growth Rate | CAGR of 20.2% from 2026 to 2031 |
| Largest Segment | PHARMACEUTICAL & BIOTECH COMPANIES (End User) |
| Market Size Base Year (Billions) | ~USD 3.97 (2026) |
| Revenue Forecast (Billions) | ~USD 9.97 (2031) |
| Segments Covered | Product, Therapeutic Area, Type, Application, End User |
South Korea Wearables in Pharma & Biotech Market Report Segmentation
5 segment dimensions are covered across the global market.
By Product
- Continuous Glucose Monitors
- Fitness Bands
- Other Products
- Patches
- Smart Rings
- Smartwatches
- Wearable Injectors
By Therapeutic Area
- Cardiovascular
- Diabetes
- Lifestyle & Wellness Improvement
- Mental Health & Behavioral Health
- Musculoskeletal Disorders/Pain Management
- Neurology
- Oncology
- Other Diseases
- Respiratory Disorders
- Women’S Health & Reproductive Health
By Type
- Atherosclerotic Cardiovascular Diseases/Secondary Prevention
- Atrial Fibrillation/Stroke Prevention
- Brain Tumor
- Breast Cancer
- Colorectal Cancer
- Heart Failure
- Hematologic Malignancies
- Hypertension
- Leukemia
- Lung Cancer
- Lymphoma
- Multiple Myeloma
- Other Hematologic Malignancies
- Other Solid Tumors
- Phase Ii
- Phase Iii
- Phase Iv
- Prostate Cancer
- Pulmonary Hypertension
- Solid Tumors
- Structural Heart Diseases/Interventional Cardiology
By Application
- Chronic Disease Monitoring
- Clinical Trials
- Drug Discovery
- Medication Adherence & Behavioral Support
- Personalized & Preventive Digital Therapeutics
By End User
- Contract Research Organizations
- Healthcare Providers & Clinicians
- Other End Users
- Pharmaceutical & Biotech Companies
Target Audience
- Medical Device Manufacturers : South Korea-based and international device makers need market intelligence to develop products aligned with Korean healthcare standards, regulatory requirements, and consumer preferences in the wearables segment.
- Pharmaceutical Companies : Pharma firms seeking to integrate wearables into drug development, clinical trials, and patient monitoring programs require South Korea-specific market data and adoption insights for strategic planning.
- Biotech Startups & Investors : Emerging biotech companies and venture capital firms targeting South Korea's high-growth wearables market need detailed market analysis, competitive positioning, and investment opportunity assessments.
- Healthcare Providers & Hospitals : South Korean hospitals and healthcare systems evaluating wearable technology adoption for patient care and remote monitoring need market data on available solutions and implementation trends.
- Government & Policy Makers : Korean health ministry officials and policy makers require market insights to inform digital health initiatives, regulatory frameworks, and investment strategies in the wearables and biotech sectors.
Key Companies in the South Korea Wearables in Pharma & Biotech Market
| Company | HQ | Ownership | Strongest segments |
|---|
Reasons to Buy this Report
- Market-Specific Growth Projections : Access precise South Korea market sizing and forecasts (2026-2031) with 19.8% CAGR, enabling accurate business planning and investment decisions tailored to this high-growth market.
- Competitive Landscape Intelligence : Understand South Korea's unique competitive dynamics, including major electronics manufacturers, local biotech firms, and international players entering the Korean market with localized strategies.
- Regulatory & Reimbursement Insights : Gain detailed knowledge of South Korean regulatory pathways, K-FDA approval processes, and healthcare reimbursement mechanisms specific to wearable pharma and biotech devices.
- Technology Adoption Trends : Identify South Korea-specific adoption patterns for remote monitoring, digital therapeutics, and AI-integrated wearables, reflecting the country's tech-savvy healthcare ecosystem.
- Strategic Partnership Opportunities : Discover key stakeholders, potential collaborators, and investment targets within South Korea's pharma, biotech, and electronics sectors for market entry and expansion strategies.
Frequently asked questions
What is the current market size of wearables in pharma & biotech in South Korea?
South Korea's wearables in pharma & biotech market was valued at $50.6 million in 2026 and is expected to grow to $124.7 million by 2031.
What is the projected growth rate for South Korea's wearables pharma market?
South Korea's market is projected to grow at a compound annual growth rate (CAGR) of 19.8% from 2026 to 2031.
What factors are driving growth in South Korea's wearables pharma sector?
South Korea's growth is driven by advanced healthcare infrastructure, strong digital health adoption, regulatory support, tech-industry partnerships, and increasing use of wearables in clinical trials and remote patient monitoring.
How does South Korea's market compare to the global wearables pharma market?
South Korea's 19.8% CAGR is slightly below the global average of 20.2%, but South Korea maintains a significant market presence with strong innovation capabilities and regional leadership in Asia Pacific.
What applications are most prevalent in South Korea's wearables pharma market?
South Korea's market is focused on real-world evidence collection, remote patient monitoring, clinical trial optimization, and personalized medicine applications leveraging wearable sensors and monitoring devices.
RESEARCH METHODOLOGY
This study involved five major activities to estimate the current size of the wearables in pharma & biotech market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to to identify and collect information for the study of the wearables in pharma & biotech market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.
Primary Research
Extensive primary research was conducted after acquiring basic knowledge about the global wearables in pharma & biotech market scenario through secondary research. Several primary interviews were conducted with market experts from both the demand side (hospital directors, hospital vice presidents, department heads, and critical care specialists) and supply side (such as C-level and D-level executives, technology experts, product managers, marketing and sales managers, among others) across five major regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.
The following is a breakdown of the primary respondents:
Note: Tiers of companies are defined based on their total revenues in 2023. Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = USD 500 million. Other designations include sales managers, marketing managers, and product managers.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the wearables in pharma & biotech market. These methods were also used extensively to estimate the size of various subsegments in the market.
The research methodology used to estimate the market size includes the following:
Wearables in Pharma & Biotech Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size using the market size estimation processes, the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and sub-segment, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the wearables in pharma & biotech market.
Market Definition
The wearables in pharma & biotech market comprise sensor-based, body-worn, or minimally invasive devices and associated digital platforms used to capture continuous physiological and behavioral data across the drug development and healthcare continuum. This includes products such as smartwatches, fitness bands, smart rings, continuous glucose monitors (CGMs), wearable patches, and wearable injectors, which enable real-time monitoring of parameters like heart rate, glucose levels, activity, and treatment adherence. These technologies are applied across a wide range of therapeutic areas, including cardiovascular diseases, oncology (solid tumors and hematologic malignancies), diabetes, mental health, respiratory, neurological, musculoskeletal, and women’s health conditions. The market spans key applications, such as drug discovery, clinical trials (Phase II–IV), medication adherence, chronic disease monitoring, and personalized digital therapeutics, supporting decentralized trials and real-world evidence generation. End users primarily include pharmaceutical and biotechnology companies, healthcare providers, and research organizations, all leveraging wearable technologies to enable data-driven, patient-centric care and more efficient drug development.
Key Stakeholders
- Wearable device & biosensor manufacturers (smartwatches, CGMs, patches, smart rings, wearable injectors)
- Digital health & software platform providers (mobile apps, cloud platforms, AI analytics)
- Component, sensor, & semiconductor technology providers
- Pharmaceutical companies
- Biotechnology companies
- Contract research organizations (CROs)
- Clinical trial sponsors & site management organizations
- Healthcare providers (hospitals, clinics, remote patient monitoring programs)
- Patients & caregivers
- Payers & insurers
- Regulatory & public health authorities (e.g., US Food and Drug Administration, European Medicines Agency)
- Academic institutions & research organizations
- Data management, interoperability & cloud infrastructure providers
- Cybersecurity & data privacy solution providers
- System integrators & IT service providers
- Venture capital & private equity firms
- Investors & financial institutions
- Consulting, regulatory, & compliance service providers
Report Objectives
- To define, describe, and forecast the wearables in pharma & biotech market based on product, therapeutic area, application, end user, and region
- To provide detailed information regarding the major factors (such as drivers, restraints, opportunities, and challenges) influencing market growth
- To strategically analyze micro-markets with respect to individual growth trends, prospects, and contributions to the overall market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To strategically analyze the market structure profile of the key players and comprehensively analyze their core competencies
- To forecast the size of the market segments with respect to five regions: North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
- To track and analyze competitive developments such as product launches and enhancements, investments, partnerships, collaborations, acquisitions, expansions, product approvals, and alliances in the market
Customization Options:
With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of each company.
Geographic Analysis
- Further breakdown of the Latin America, Europe, and the Middle East & Africa markets into specific countries
Get the Full Wearables in Pharma & Biotech Market Report
Full forecast, segment splits, and company analysis for all Wearables in Pharma & Biotech Market.
- US Wearables in Pharma & Biotech Market
- Canada Wearables in Pharma & Biotech Market
- Germany Wearables in Pharma & Biotech Market
- France Wearables in Pharma & Biotech Market
- UK Wearables in Pharma & Biotech Market
- Italy Wearables in Pharma & Biotech Market
- Spain Wearables in Pharma & Biotech Market
- China Wearables in Pharma & Biotech Market
- Japan Wearables in Pharma & Biotech Market
- India Wearables in Pharma & Biotech Market
- Australia Wearables in Pharma & Biotech Market
- Brazil Wearables in Pharma & Biotech Market
- Mexico Wearables in Pharma & Biotech Market
- Saudi Arabia Wearables in Pharma & Biotech Market
- UAE Wearables in Pharma & Biotech Market
- South Africa Wearables in Pharma & Biotech Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report